Study on Antiviral Therapy for HBeAg-positive Chronic Hepatitis B Patients Aged 1-16 Years

Condition:   HBeAg Positive Chronic Hepatitis B Intervention:   Drug: ETV+PegIFN-α Sponsor:   Beijing 302 Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials